Intelligent Bio Solutions Inc.

About Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc. (INBS) is a company focused on pioneering pain-free solutions through technology. Their mission is to redefine testing approaches and deliver accessible, transformative solutions that improve quality of life.

Products & Services

Intelligent Fingerprinting Drug Test:A portable drug screening solution that detects commonly abused drugs via sweat from fingertips, offering ease of use and results within 16-24 hours of potential misuse.

Intelligent Drug Screening:A dignified drug screening system that tests fingertip sweat for recent use of drugs like cannabis, cocaine, opiates, and methamphetamine, with sample collection in under a minute and results in under ten minutes.

The Biosensor Platform:A small, printable organic strip designed for multiple diagnostic tests, enabling accurate and timely diagnosis for patients and health practitioners.

Specialties

Non-invasive Drug Testing Fingerprint Sweat Analysis Biosensor Technology Portable Diagnostic Solutions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 10000000 MR: - FA: $10.0 million FAN: 10000000	D: 2026-01-02 FD: 2026-01-02	1 investors
2	RT: Private Placement T: - FT: Private Placement	A: 10000000 MR: - FA: 10.0 million FAN: 10000000	D: 2025-12-31 FD: 2025-12-31	1 investors
3	RT: Warrant Exercise and Private Placement T: - FT: Warrant Exercise and Private Placement	A: 3800000 MR: - FA: $3.8 million FAN: 3800000	D: 2025-07-25 FD: 2025-07-25	2 investors
4	RT: Public Offering T: - FT: Public Offering	A: 3000000 MR: - FA: approximately $3.0 million FAN: 3000000	D: 2025-02-21 FD: 2025-02-21	1 investors
5	RT: Public Offering T: - FT: Public Offering	A: 2600000 MR: - FA: approximately $2.6 million FAN: 2600000	D: 2025-02-20 FD: 2025-02-20	1 investors
6	RT: Private Placement T: - FT: Private Placement	A: 10100000 MR: - FA: approximately $10.1 million FAN: 10100000	D: 2024-03-12 FD: 2024-03-12	-
7	RT: Private Placement T: - FT: Private Placement	A: 10100000 MR: - FA: 10.1 million FAN: 10100000	D: 2024-03-11 FD: 2024-03-11	1 investors
8	RT: Warrant Exercise T: - FT: Warrant Exercise	A: 1770000 MR: - FA: 1.77 million FAN: 1770000	D: 2024-02-05 FD: 2024-02-05	1 investors
9	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 4378000 MR: - FA: approximately $4.378 million FAN: 4378000	D: 2023-10-04 FD: 2023-10-04	1 investors
10	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 4000000 MR: - FA: 4.0 million FAN: 4000000	D: 2023-10-02 FD: 2023-10-02	1 investors
11	RT: Grant T: - FT: Grant	A: 1430000 MR: - FA: USD $1.43 million FAN: 1430000	D: 2023-06-20 FD: 2023-06-20	1 investors
12	RT: Public Offering T: - FT: Public Offering	A: 2550000 MR: - FA: $2.55 million FAN: 2550000	D: 2023-03-10 FD: 2023-03-10	1 investors
13	RT: Public Offering T: - FT: Public Offering	A: 2200000 MR: - FA: approximately $2.2 million FAN: 2200000	D: 2023-03-08 FD: 2023-03-08	1 investors

Private Placement Latest

2026-01-02

$10.0M

1 investor (Pro only)

Private Placement 2025-12-31

$10.0M

Warrant Exercise and Private Placement 2025-07-25

$3.8M

View 12 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

H

Harry Simeonidis

President & CEO

S

Spiro Sakiris

Chief Financial Officer

D

Doug Heath

Vice President of Global Sales

P

Peter Passaris

Vice President of Product Development

A

Anna Turkington

Vice President of Marketing

R

Rafael Da Luz

Vice President of Regulatory Affairs

View 9 more team members with Pro

Unlock Full Team Directory

Recent News